Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 USD | -10.45% | -11.76% | -69.07% |
May. 08 | UBS Adjusts Price Target on Stem to $2.50 From $5, Maintains Buy Rating | MT |
May. 02 | Transcript : Stem, Inc., Q1 2024 Earnings Call, May 02, 2024 |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- The company has a poor ESG score according to Refinitiv, which ranks companies by sector.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- With regards to fundamentals, the enterprise value to sales ratio is at 1.01 for the current period. Therefore, the company is undervalued.
- The company appears to be poorly valued given its net asset value.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Renewable Energy Equipment & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-69.07% | 194M | D+ | ||
+102.33% | 20.45B | B- | ||
-24.57% | 6.45B | B | ||
-15.07% | 3.19B | C+ | ||
-20.66% | 2.48B | B | ||
-24.05% | 1.94B | D+ | ||
-19.64% | 1.23B | - | ||
+2.71% | 1.07B | - | - | |
-9.17% | 919M | - | ||
+83.91% | 902M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- STEM Stock
- Ratings Stem, Inc.